St. Jude Targets Amgen Over DNA, Cancer Research Patents

By Brian Mahoney (April 9, 2014, 3:48 PM EDT) -- St. Jude Children's Research Hospital Inc. on Tuesday sued Amgen Inc. in Tennessee federal court, alleging the company obtained patented DNA and nucleic acids material used for fighting cancer and unlawfully licensed them to Tesaro Inc. for a potential payout exceeding $100 million....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!